PEGBIO CO-B(02565) appointed Liao Yilin as an independent non-executive director.
Pegasus BioMedicine-B (02565) announced that Ms. Liao Yilin has been appointed as an independent non-executive director of the second board of directors, with a term starting from June 24, 2026 until the end of the term of the second board of directors. Ms. Liao Yilin will serve as the chairman of the audit committee, and as a member of the remuneration and appraisal committee and the nomination committee, with a term consistent with her appointment as an independent non-executive director of the second board of directors.
PEGBIO CO-B(02565) announcement, Ms. Liao Yilin has been appointed as an independent non-executive director of the second board of directors, with a term starting from June 24, 2026 until the completion of the term of the second board of directors. Ms. Liao Yilin will serve as the chairman of the audit committee, as well as a member of the compensation and assessment committee and the nomination committee, with a term consistent with her appointment as an independent non-executive director of the second board of directors.
Related Articles
HK FINANCE GP (01273) announced its annual performance, with a net profit of HK$70.12 million, a year-on-year increase of 51.9%.
On June 24th, XD INC (02400) spent approximately 7.9115 million Hong Kong dollars to repurchase 180,000 shares.
KARRIE INT'L (01050) will distribute a final dividend of HK$0.045 per share on September 22nd.
HK FINANCE GP (01273) announced its annual performance, with a net profit of HK$70.12 million, a year-on-year increase of 51.9%.
On June 24th, XD INC (02400) spent approximately 7.9115 million Hong Kong dollars to repurchase 180,000 shares.
KARRIE INT'L (01050) will distribute a final dividend of HK$0.045 per share on September 22nd.
RECOMMEND
